Recombinant immune interferon down-regulates Ha-ras-1 proto-oncogene products in a human melanoma cell line

P. Giacomini, R. Gambari, R. Barbieri, C. Nastruzzi, R. Fraioli, D. Spandidos, P. B. Fisher, P. G. Natali

Research output: Contribution to journalArticle

Abstract

The antiproliferative and antineoplastic effects of the interferons may result, at least in part, from changes in the expression and quantity of specific oncogene products. To explore this hypothesis we have determined the effect of interferons, including recombinant leukocyte (IFN-α), fibroblast (IFN-β) and immune (IFN-γ), on expression of the Ha-ras proto-oncogene in the human melanoma cell line Colo 38. While concentrations of up to 1000 U/ml of either IFN-α or IFN-β did not affect the total amounts of Ha-ras products, IFN-γ at concentrations ranging from 20 to 200 U/ml caused a dose- and time-dependent (48-96 hr) reduction (approximately 40%) in the accumulation of Ha-ras-1 mRNA and in the synthesis of the specific protein products. Downregulation of this proto-oncogene occurs prior to the antiproliferative effects of IFN-γ and parallels similar IFN-γ mediated changes in the expression of certain melanoma associated antigens. The present findings indicate that this experimental model may prove valuable in determining whether a direct relationship exists between the antiproliferative activity of specific interferons and the downregulation of oncogene expression.

Original languageEnglish
Pages (from-to)629-635
Number of pages7
JournalAnticancer Research
Volume10
Issue number3
Publication statusPublished - 1990

Fingerprint

Proto-Oncogenes
Oncogene Proteins
Interferons
Interferon-gamma
Melanoma
Down-Regulation
Cell Line
Melanoma-Specific Antigens
ras Genes
Oncogenes
Antineoplastic Agents
Leukocytes
Theoretical Models
Fibroblasts
Messenger RNA
Proteins

Keywords

  • Ha-ras-1 Expression
  • IFN-α
  • IFN-β
  • IFN-γ

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Giacomini, P., Gambari, R., Barbieri, R., Nastruzzi, C., Fraioli, R., Spandidos, D., ... Natali, P. G. (1990). Recombinant immune interferon down-regulates Ha-ras-1 proto-oncogene products in a human melanoma cell line. Anticancer Research, 10(3), 629-635.

Recombinant immune interferon down-regulates Ha-ras-1 proto-oncogene products in a human melanoma cell line. / Giacomini, P.; Gambari, R.; Barbieri, R.; Nastruzzi, C.; Fraioli, R.; Spandidos, D.; Fisher, P. B.; Natali, P. G.

In: Anticancer Research, Vol. 10, No. 3, 1990, p. 629-635.

Research output: Contribution to journalArticle

Giacomini, P, Gambari, R, Barbieri, R, Nastruzzi, C, Fraioli, R, Spandidos, D, Fisher, PB & Natali, PG 1990, 'Recombinant immune interferon down-regulates Ha-ras-1 proto-oncogene products in a human melanoma cell line', Anticancer Research, vol. 10, no. 3, pp. 629-635.
Giacomini, P. ; Gambari, R. ; Barbieri, R. ; Nastruzzi, C. ; Fraioli, R. ; Spandidos, D. ; Fisher, P. B. ; Natali, P. G. / Recombinant immune interferon down-regulates Ha-ras-1 proto-oncogene products in a human melanoma cell line. In: Anticancer Research. 1990 ; Vol. 10, No. 3. pp. 629-635.
@article{f1831f166b694876b4f48f3ef6410eea,
title = "Recombinant immune interferon down-regulates Ha-ras-1 proto-oncogene products in a human melanoma cell line",
abstract = "The antiproliferative and antineoplastic effects of the interferons may result, at least in part, from changes in the expression and quantity of specific oncogene products. To explore this hypothesis we have determined the effect of interferons, including recombinant leukocyte (IFN-α), fibroblast (IFN-β) and immune (IFN-γ), on expression of the Ha-ras proto-oncogene in the human melanoma cell line Colo 38. While concentrations of up to 1000 U/ml of either IFN-α or IFN-β did not affect the total amounts of Ha-ras products, IFN-γ at concentrations ranging from 20 to 200 U/ml caused a dose- and time-dependent (48-96 hr) reduction (approximately 40{\%}) in the accumulation of Ha-ras-1 mRNA and in the synthesis of the specific protein products. Downregulation of this proto-oncogene occurs prior to the antiproliferative effects of IFN-γ and parallels similar IFN-γ mediated changes in the expression of certain melanoma associated antigens. The present findings indicate that this experimental model may prove valuable in determining whether a direct relationship exists between the antiproliferative activity of specific interferons and the downregulation of oncogene expression.",
keywords = "Ha-ras-1 Expression, IFN-α, IFN-β, IFN-γ",
author = "P. Giacomini and R. Gambari and R. Barbieri and C. Nastruzzi and R. Fraioli and D. Spandidos and Fisher, {P. B.} and Natali, {P. G.}",
year = "1990",
language = "English",
volume = "10",
pages = "629--635",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - Recombinant immune interferon down-regulates Ha-ras-1 proto-oncogene products in a human melanoma cell line

AU - Giacomini, P.

AU - Gambari, R.

AU - Barbieri, R.

AU - Nastruzzi, C.

AU - Fraioli, R.

AU - Spandidos, D.

AU - Fisher, P. B.

AU - Natali, P. G.

PY - 1990

Y1 - 1990

N2 - The antiproliferative and antineoplastic effects of the interferons may result, at least in part, from changes in the expression and quantity of specific oncogene products. To explore this hypothesis we have determined the effect of interferons, including recombinant leukocyte (IFN-α), fibroblast (IFN-β) and immune (IFN-γ), on expression of the Ha-ras proto-oncogene in the human melanoma cell line Colo 38. While concentrations of up to 1000 U/ml of either IFN-α or IFN-β did not affect the total amounts of Ha-ras products, IFN-γ at concentrations ranging from 20 to 200 U/ml caused a dose- and time-dependent (48-96 hr) reduction (approximately 40%) in the accumulation of Ha-ras-1 mRNA and in the synthesis of the specific protein products. Downregulation of this proto-oncogene occurs prior to the antiproliferative effects of IFN-γ and parallels similar IFN-γ mediated changes in the expression of certain melanoma associated antigens. The present findings indicate that this experimental model may prove valuable in determining whether a direct relationship exists between the antiproliferative activity of specific interferons and the downregulation of oncogene expression.

AB - The antiproliferative and antineoplastic effects of the interferons may result, at least in part, from changes in the expression and quantity of specific oncogene products. To explore this hypothesis we have determined the effect of interferons, including recombinant leukocyte (IFN-α), fibroblast (IFN-β) and immune (IFN-γ), on expression of the Ha-ras proto-oncogene in the human melanoma cell line Colo 38. While concentrations of up to 1000 U/ml of either IFN-α or IFN-β did not affect the total amounts of Ha-ras products, IFN-γ at concentrations ranging from 20 to 200 U/ml caused a dose- and time-dependent (48-96 hr) reduction (approximately 40%) in the accumulation of Ha-ras-1 mRNA and in the synthesis of the specific protein products. Downregulation of this proto-oncogene occurs prior to the antiproliferative effects of IFN-γ and parallels similar IFN-γ mediated changes in the expression of certain melanoma associated antigens. The present findings indicate that this experimental model may prove valuable in determining whether a direct relationship exists between the antiproliferative activity of specific interferons and the downregulation of oncogene expression.

KW - Ha-ras-1 Expression

KW - IFN-α

KW - IFN-β

KW - IFN-γ

UR - http://www.scopus.com/inward/record.url?scp=0025374829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025374829&partnerID=8YFLogxK

M3 - Article

C2 - 2114818

AN - SCOPUS:0025374829

VL - 10

SP - 629

EP - 635

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3

ER -